5D·

Purchase decision

Hello everyone. I'm currently having a hard time deciding...like probably so many people. I was considering either opening a new position at $FTNT (+0,66%) as this would be penalized too much or to buy a position in $NOVO B (+1,53%) . However, I think that the recovery will drag on like chewing gum and will certainly not be a v-shaped recovery.

What do you think and what do you currently have on your whatchlist?

15Posições

8,29%

9 Comentários

Silas W.@DynasticGrind

In my opinion, Novo has been overrated for a long time because the public focus was extremely strong on the weight loss injection. For the average citizen, delivery syringes have roughly the same effect as a special fuel designed to compensate for a shortfall in engine capacity. The correction was to be expected, in my opinion, and the company is also in a good fundamental position. For me, Novo is not a growth stock, but at best a dividend stock, which should at least hold up well due to its strong market position. I do not expect a rocket launch in the direction of €100 or similar.

•

K@TechNav

There are good reasons why they have sunk so low.

•

Ver todas as 6 restantes respostas

ShrimpTheGimp🦐@ShrimpTheGimp

You would have the opportunity to significantly reduce your buy-in at $NOVO B. But the shot can of course also backfire 😉

••